Sohal A, Singh C, Bhalla A, Kalsi H, Roytman M
J Clin Med. 2024; 13(18).
PMID: 39337023
PMC: 11433393.
DOI: 10.3390/jcm13185536.
Ji L, Gao X, Xiao W, Yu S
Front Cardiovasc Med. 2024; 11:1407531.
PMID: 39045007
PMC: 11265283.
DOI: 10.3389/fcvm.2024.1407531.
Sallam M, Khalil R
Microorganisms. 2024; 12(6).
PMID: 38930417
PMC: 11205832.
DOI: 10.3390/microorganisms12061035.
Gela Y, Limenh L, Simegn W, Ayenew W, Chanie G, Seid A
Front Med (Lausanne). 2024; 11:1366010.
PMID: 38751978
PMC: 11094326.
DOI: 10.3389/fmed.2024.1366010.
Gela Y, Tesfaye W, Melese M, Getnet M, Ambelu A, Eshetu H
Sci Rep. 2024; 14(1):6812.
PMID: 38514836
PMC: 10957902.
DOI: 10.1038/s41598-024-57512-1.
Global epidemiology of hepatitis C virus in dialysis patients: A systematic review and meta-analysis.
Kenfack-Momo R, Djuidje Ngounoue M, Kenmoe S, Takuissu G, Ebogo-Belobo J, Kengne-Nde C
PLoS One. 2024; 19(2):e0284169.
PMID: 38330063
PMC: 10852299.
DOI: 10.1371/journal.pone.0284169.
Regular laboratory testing and patient survival among patients undergoing maintenance hemodialysis: a Korean nationwide cohort study.
Kim D, Cho A, Park H, Kim B, Lee M, Kim G
Sci Rep. 2023; 13(1):18360.
PMID: 37884647
PMC: 10603026.
DOI: 10.1038/s41598-023-45502-8.
Sofosbuvir and Velpatasvir Regimen Outcome for Chronic Hepatitis C Patients With End-Stage Renal Disease Undergoing Hemodialysis.
Shahid S, Asghar S, Mahmood T, Fatima M, Rasheed A, Asghar S
Cureus. 2023; 15(9):e45680.
PMID: 37868481
PMC: 10590019.
DOI: 10.7759/cureus.45680.
Opportunities for Enhanced Prevention and Control of Hepatitis C Through Improved Screening and Testing Efforts.
Cartwright E, Patel P
J Infect Dis. 2023; 229(Supplement_3):S350-S356.
PMID: 37739791
PMC: 10961945.
DOI: 10.1093/infdis/jiad199.
The Seroprevalence of Hepatitis C Virus (HCV) in Hemodialysis Patients in Oman: A National Cross-Sectional Study.
Al Shukri I, Al Wahaibi A, Al Kindi H, Al-Maimani Y, Al Maani A, Alqayoudhi A
J Epidemiol Glob Health. 2023; 13(4):774-781.
PMID: 37698781
PMC: 10686920.
DOI: 10.1007/s44197-023-00149-6.
Interventions for dialysis patients with hepatitis C virus (HCV) infection.
Prabhu A, Rao I, Nagaraju S, Rajwar E, Venkatesh B, Nair N S
Cochrane Database Syst Rev. 2023; 4:CD007003.
PMID: 37096802
PMC: 10130818.
DOI: 10.1002/14651858.CD007003.pub3.
A Systematic Review of Direct-Acting Antivirals for Hepatitis C in Advanced CKD.
Balk E, Adam G, Jadoul M, Martin P, Gordon C
Kidney Int Rep. 2023; 8(2):240-253.
PMID: 36815114
PMC: 9939364.
DOI: 10.1016/j.ekir.2022.11.008.
Prevalence of Cardio-Embolic Brain Complications in Permanent and Paroxysmal Atrial Fibrillation Patients.
Rosca C, Sharma A, Nisulescu D, Otiman G, Duda-Seiman D, Morariu S
Healthcare (Basel). 2023; 11(2).
PMID: 36673543
PMC: 9858915.
DOI: 10.3390/healthcare11020175.
Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis C Virus Infection.
Songtanin B, Nugent K
Biology (Basel). 2023; 12(1).
PMID: 36671716
PMC: 9855523.
DOI: 10.3390/biology12010023.
External validation of the risk prediction model for early diabetic kidney disease in Taiwan population: a retrospective cohort study.
Sun Z, Wang K, Miller J, Yuan X, Lee Y, Lou Q
BMJ Open. 2022; 12(12):e059139.
PMID: 36523225
PMC: 9748925.
DOI: 10.1136/bmjopen-2021-059139.
The world prevalence, associated risk factors and mortality of hepatitis C virus infection in hemodialysis patients: a meta-analysis.
Greeviroj P, Lertussavavivat T, Thongsricome T, Takkavatakarn K, Phannajit J, Avihingsanon Y
J Nephrol. 2022; 35(9):2269-2282.
PMID: 36383211
PMC: 9666992.
DOI: 10.1007/s40620-022-01483-x.
Safety and Efficacy of Direct-acting Antiviral Therapies for Chronic HCV Infection in Hemodialysis Patients.
Droc G, Istrate M, Mercan-Stanciu A, Dodot M, Isac T, Toma L
In Vivo. 2022; 36(6):2918-2922.
PMID: 36309363
PMC: 9677749.
DOI: 10.21873/invivo.13033.
Safety and effectiveness of direct-acting antivirals in patients with chronic hepatitis C and chronic kidney disease.
Ryu J, Song M, Kim S, Kwon J, Yoo S, Nam S
Korean J Intern Med. 2022; 37(5):958-968.
PMID: 35981893
PMC: 9449192.
DOI: 10.3904/kjim.2021.486.
Executive summary of the Korean Society of Nephrology 2021 clinical practice guideline for optimal hemodialysis treatment.
Jung J, Yoo K, Kang E, Kang H, Kim S, Kim H
Korean J Intern Med. 2022; 37(4):701-718.
PMID: 35811360
PMC: 9271711.
DOI: 10.3904/kjim.2021.543.
Hepatitis C Prevalence, Incidence, and Treatment in Chinese Hemodialysis Patients: Results From the Dialysis Outcomes and Practice Patterns Study-China (2019-21).
Gan L, Wang D, Bieber B, McCullough K, Jadoul M, Pisoni R
Front Med (Lausanne). 2022; 9:910840.
PMID: 35783631
PMC: 9240809.
DOI: 10.3389/fmed.2022.910840.